Bad-ang et al., 2025 - Google Patents
Human microbiome and genito-urinary disordersBad-ang et al., 2025
- Document ID
- 5305323491089085012
- Author
- Bad-ang M
- Jayakumar D
- Bansal A
- Kolkar K
- Joseph K
- Deshpande A
- Wee A
- Sivaraj A
- Publication year
- Publication venue
- Human Microbiome Drug Targets
External Links
Snippet
The use of microbiome in the different urinary disorders, such as kidney stones and urothelial cancer, the studies from different animal models have already produced convincing results, wherein the theoretical basis of most organisms of possible clinical use …
- 244000005702 human microbiome 0 title description 10
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K8/00—Cosmetic or similar toilet preparations
- A61K8/18—Cosmetic or similar toilet preparations characterised by the composition
- A61K8/96—Cosmetic or similar toilet preparations characterised by the composition containing material, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetic or similar toilet preparations characterised by the composition containing material, or derivatives thereof of undetermined constitution from micro-organisms
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sotoudegan et al. | Reappraisal of probiotics’ safety in human | |
| US11116806B2 (en) | Composite probiotic lactic acid bacteria powder and preparation method and use thereof | |
| Domingo | Review of the role of probiotics in gastrointestinal diseases in adults | |
| JP2024003162A (en) | New use for treatment of clostridium difficile infections | |
| US7901925B2 (en) | Lactobacillus delbrueckii ssp. bulgaricus strain and compositions | |
| Hekmat et al. | Growth and survival of Lactobacillus reuteri RC-14 and Lactobacillus rhamnosus GR-1 in yogurt for use as a functional food | |
| EP2114423B2 (en) | Inactivated lactobacillus rhammosus gg for treating systemic inflammation in infants | |
| US8771673B2 (en) | Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions | |
| JP5137571B2 (en) | Methods and compositions for dietary management of autoimmune disorders | |
| Atabati et al. | Probiotics with ameliorating effects on the severity of skin inflammation in psoriasis: Evidence from experimental and clinical studies | |
| US8246946B2 (en) | Treatment of bipolar disorder utilizing anti-fungal compositions | |
| US9962415B2 (en) | Lachnospiraceae in the gut microbiota and association with body weight | |
| Kim et al. | Lactobacillus brevis OK56 ameliorates high-fat diet-induced obesity in mice by inhibiting NF-κB activation and gut microbial LPS production | |
| Kolida et al. | Gastrointestinal microflora: probiotics | |
| Li et al. | Synbiotic yogurt containing konjac mannan oligosaccharides and Bifidobacterium animalis ssp. lactis BB12 alleviates constipation in mice by modulating the stem cell factor (SCF)/c-Kit pathway and gut microbiota | |
| CN101998834B (en) | Probiotics for use in relieving symptoms associated with gastrointestinal disorders | |
| Luo et al. | Comprehensive in silico analysis of the probiotics, and preparation of compound probiotics-Polygonatum sibiricum saponin with hypoglycemic properties | |
| WO2018112739A1 (en) | Bifidobacterium pseudocatenulatum, culture method therefor and application thereof | |
| Hickson | Examining the evidence for the use of probiotics in clinical practice | |
| CN114745970A (en) | Method for promoting the production of SCFA by intestinal microbiota | |
| Jaiswal et al. | A study on the assessment of the antimicrobial susceptibility pattern of microorganisms present in yogurt | |
| CN115093999A (en) | A strain of Clostridium prazines that can improve dyslipidemia and its application | |
| Arora et al. | Therapeutic potential of probiotics: A ray of hope or nightmare? | |
| WO2008002484A2 (en) | Novel lactobacillus bulgaricus strain and compositions | |
| Bad-ang et al. | Human microbiome and genito-urinary disorders |